Ideas catalog
Every idea we've derived from recent research — the ones marked “Prototype” come with a live demo you can try.
A high-utility tool that solves a specific pain point in data consulting, though it faces significant technical hurdles regarding deep integration with proprietary BI software.
A clinically validated wear-tracking feature with a clear behavioral wedge, but it's a thin feature dependent on incumbents who already own sensor and monitoring infrastructure.
Backed by 2 papers
A targeted software optimization to solve the 'over-cautious' AV problem, though it faces high integration hurdles with existing safety-critical stacks.
A promising but narrow optimization for ADAS that addresses passenger psychology, though it faces significant regulatory and safety-validation hurdles.
A sharply focused decision-support tool that wisely narrows to the single high-stakes C-vs-D suture maturation call, but rests on essentially one research group's small-sample evidence and faces real regulatory and data-acquisition hurdles.
Backed by 2 papers
A viable but incremental manufacturing play that targets a niche high-end orthodontic segment to compete with clear aligners.
A low-moat decision-support tool that translates a specific academic weighting exercise into a consultancy service, lacking a proprietary technical edge.
A scientifically grounded but explicitly paper-suggested TrkB PAM concept for non-hallucinogenic antidepressants that is technically ambitious and entering a rapidly crowding competitive space, making commercial differentiation the key risk rather than scientific rationale.
Backed by 2 papers
A niche professional development tool that converts a specific academic research method into a product, though it faces significant headwinds regarding buyer urgency and scalability.
A focused tool to solve the 'interaction gap' in BI, though it risks being a feature rather than a standalone product.
A useful utility tool that addresses a real pain point in data storytelling, though it faces significant integration hurdles with closed-ecosystem BI platforms.
A high-risk clinic model that attempts to operationalize psychedelic therapy, but is currently blocked by severe regulatory hurdles and a lack of clear reimbursement pathways.
Backed by 4 papers
A niche hardware play targeting fleet emissions compliance, though it faces significant mechanical complexity and a potential conflict between emission reduction and tire longevity.
Backed by 2 papers
A niche optimization tool that leverages a clear linear relationship between tire pressure/load and emissions, though it faces significant operational hurdles in real-time implementation.
Backed by 2 papers
A promising technical approach to edge AI, but currently framed as a generic service rather than a specific product, making it a feature for chipmakers rather than a standalone business.
Backed by 2 papers
A niche B2B tool with clear utility for compliance, but currently lacks a concrete predictive mechanism beyond a general literature review.
A high-risk clinical service model that relies on a substance currently lacking broad regulatory approval and faces significant operational hurdles despite promising efficacy data.
Backed by 3 papers
A niche academic tool with limited commercial viability, as it solves a specific scholarly debate rather than a scalable market pain point.
A high-risk pharmaceutical play that translates a promising mouse-model finding into a clinical kit, though it faces significant regulatory hurdles and biological scaling risks.
A niche professional development play that converts a specific research gap into a certification, though it lacks a strong commercial moat and relies on a single study.